ECMO Machine Market Highlights

• Global ECMO machine market revenue is poised to garner USD 887.1 million by 2032 with a CAGR of 5.2% from 2023 to 2032
• North America ECMO machine market value occupied around USD 211.6 million in 2022
• Asia-Pacific ECMO machine market growth will record a CAGR of more than 6% from 2023 to 2032
• Among component, the oxygenators sub-segment generated over US$ 189.9 million revenue in 2022
• Based on patient type, the adult sub-segment generated around 59% share in 2022
• Development of portable and user-friendly devices is a popular ECMO machine market trend that fuels the industry demand

Extracorporeal membrane oxygenation (ECMO) market is a system that supports patients with severe respiratory failure in their heart and lungs. The ECMO circuit includes cannulas, pumps, blenders, and oxygenators, which oxygenate the blood and remove carbon dioxide via the membrane oxygenator (OOD). The placement of the cannula's drainage and reinfusion ports determines the ECMO model. If both the drainage and reinfusion occur in central veins, it is called venovenous ECMO; if it involves a combination of venous and arterial access, it is termed veno-arterial ECMO. Potential indications for ECMO include severe acute respiratory distress syndrome (ARDS), acute hypercapnic respiratory failure, bridging to lung transplant, primary post-lung graft dysfunction, and right ventricular failure due to pulmonary hypertension.

Global ECMO Machine Market Dynamics

Market Drivers

• Increasing prevalence of respiratory diseases
• Technological advancements in ECMO machines
• Growing awareness and adoption of ECMO therapies
• Rising cases of cardiopulmonary disorders worldwide

Market Restraints

• High cost associated with ECMO therapy
• Limited expertise and skilled professionals
• Potential risks of complications during ECMO treatment

Market Opportunities

• Expanding applications in pediatric care
• Rising investment in healthcare infrastructure
• Collaborations and strategic partnerships in the ECMO industry

ECMO Machine Market Report Coverage

Extracorporeal Membrane Oxygenation ECMO Machine Market Insights

The primary market drivers include the increasing incidences of chronic obstructive pulmonary disorder (COPD), heart disease, and respiratory failure. ECMO machines find key applications in managing cardiopulmonary failure, cardiogenic shock, and respiratory failure. This treatment can also be recommended for patients undergoing heart or lung transplant surgery. In the U.S., nearly 6.0% of the mature population was diagnosed with COPD, which was estimated to be the third leading cause of death in the country, according to the American Journal of Respiratory and Critical Care Medicine.

Moreover, according to the European Respiratory Journal, almost 50 to 90 percent of the COPD burden goes undiagnosed. The anticipated surge in demand is expected to drive increased product demand for effective critical care throughout the ECMO machine industry forecast period. The number of ECMO centers saw a significant rise following the integration of ECMO machinery in treating and managing the swine flu epidemic in 2009.

Furthermore, there's an anticipated escalation in demand for emergency care due to increased tobacco consumption and resulting lifestyle disorders. The growing application of ECMO machines in treating respiratory disorders is bolstering their popularity in hospital and medical systems. These machines are utilized not only in cases of cardiac failure but also in neonatal and pediatric care to provide auxiliary oxygen support.

ECMO Machine Market Segmentation

The worldwide market for ECMO machine market is split based on component, modality, patient type, application, and geography.

Extracorporeal Membrane Oxygenation Machine Market By Component

• Pumps
• Controllers
• Oxygenators
• Accessories
• Cannula

The ECMO machine market is categorized into pumps, controllers, oxygenators, cannulae, and accessories based on their components. Due to factors such as the increased incidence of severe lung diseases and heightened awareness regarding the applications of ECMO machines, the oxygenators segment is anticipated to dominate the market. For instance, in 2017, approximately 28,600 people were diagnosed with cancer in Canada, as reported by the Canadian Lung Association.

Every year, more than 11 million people receive a COPD diagnosis, according to the American Lung Association. Additionally, the World Health Organization (WHO) reported that in 2015, over 3 million individuals in Japan suffered from asthma, with 7% categorized as severe and 30% as moderately asthmatic. In 2012, Europe witnessed approximately 40,000 deaths due to respiratory diseases, constituting 8% of the total deaths reported in the same year according to Eurostat statistics.

Extracorporeal Membrane Oxygenation Machine Market By Modality

• Arterio-Venous (AV)
• Veno-Venous (VV)
• Veno-Arterial (VA)

The ECMO machine market is segmented into arteriovenous, venoarterial, and venovenous modalities. These modalities serve to support hemodynamics and facilitate gas exchange for patients experiencing cardiac or respiratory insufficiency. The veno-arterial ECMO system functions by providing both gas exchange and hemodynamic support, primarily by circulating blood from the patient's heart and lungs to the ECMO system. In contrast, the venovenous system solely aids in gas exchange, circulating blood before it returns to the heart.

According to the extracorporeal membrane oxygenation ECMO machine market analysis, In specific cases like cardiogenic shock, the National Institutes of Health (NIH) in the United States employ veno-venous and veno-arterial combinations. The veno-arterial segment led the market in 2022 and is projected to expand due to its extensive range of treatments for cardiovascular collapse. Veno-arterial systems are utilized for treating and managing reduced heart output and tissue hypoperfusion, resulting in cardiogenic shock, which can trigger myocardial or chronic ischemia. It is essential in preventing these conditions.

Extracorporeal Membrane Oxygenation Machine Market By Patient Type

• Neonates
• Pediatric
• Adult

In recent years, the Adult segment has emerged as the dominant patient type segment in the extracorporeal membrane oxygenation machine market. The increasing demand for enhanced security measures in various sectors, including Neonates areas, Adults neighborhoods, and other monitored spaces, has necessitated the use of Adult robots. This significant demand for Adult robots is a key driver for the market's growth. Two noteworthy patient types of mobile robots include Adult and gas leak detection systems.

Another prominent patient type segment is Neonates, which holds the second-largest market share after Adult. The Neonates segment is expected to exhibit the highest compound annual growth rate (CAGR) during the forecast period. As there is a growing emphasis on safety and heightened security at national borders, there is often a shortage of manpower for effective security monitoring. This creates a need for Adult robots, and this segment is anticipated to significantly contribute to the market's growth in the coming years.

Extracorporeal Membrane Oxygenation Machine Market By Application

• Cardiac
  • Adults
  • Neonates
  • Pediatric
• Respiratory
  • Adults
  • Neonates
  • Pediatric
• Extracorporeal Cardiopulmonary Resuscitation (ECPR)
  • Adults
  • Neonates
  • Pediatric

The extracorporeal cardiopulmonary re-resuscitation (ECPR), respiratory, and cardiac markets are segmented by application, further divided into neonatal, pediatric, and adult care categories. In 2022, the respiratory section dominated the ECMO machinery market, representing over 45% of the global share. This predominance is attributed to ECMO's role as artificial lungs, crucial in supporting pulmonary function.

According to a 2016 report from the Extracorporeal Life Support Organization, approximately 45,035 patients worldwide suffered from respiratory diseases necessitating extracorporeal membrane oxygenation therapies. In 2022, ECMO held the largest share in the adult segment, with predicted profit growth in the forecast period. This growth is associated with the increased prevalence of COPD and related cardiopulmonary conditions in adults. ECMO systems are utilized as artificial heart treatment for severe cardiac conditions like cardiac arrest or shock.

The same recent years report indicated that approximately 22,140 patients worldwide suffered from cardiac conditions requiring ECMO. Rescue Therapy, also known as extracorporeal heart pulmonary resuscitation (ECPR), is utilized for treating patients experiencing cardiac arrest both inside and outside the hospital. In past year, nearly 6,421 individuals worldwide required ECPR, as reported by the Extracorporeal Life Support Organization. Neonates not responding to high-frequency ventilation may be recommended ECMO as a treatment option.

Venous ECMO is primarily used due to a higher survival rate compared to arterial ECMO. The increased demand for ECMO systems is largely attributed to the rising cases of chronic diseases such as COPD, emphysema, and chronic bronchitis, alongside increased awareness of health disorders, particularly in the United States. In 2014, the National Center for Health Statistics reported over 8.7 million people with chronic bronchitis and 3.4 million with emphysema.

Extracorporeal Membrane Oxygenation Machine Market By Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Extracorporeal Membrane Oxygenation (ECMO) Machine Market Regional Analysis

In terms of ECMO industry analysis the North America secured the largest market share in 2022 due to its well-established primary, secondary, and tertiary hospitals, structured repayment frameworks, favorable government funding, and an enhanced understanding of ECMO systems, facilitating their widespread use in hospitals.

According to the ECMO machine forecast period, the Asia-Pacific region is anticipated to emerge as the fastest-growing regional market. This growth is attributed to the escalating incidence of lung cancer in countries such as China and India. Annually, China records 781,000 new lung cancer diagnoses, as reported by the National Cancer Center (NCC), making it one of the leading causes of cancer-related deaths in the country.

Extracorporeal Membrane Oxygenation Machine Market Players

Some of the top extracorporeal membrane oxygenation ECMO machine companies offered in our report includes Abbott, ALung Technologies, Inc., Braile Biomédica, EUROSETS, Fresenius Medical Care AG & Co. KGaA, Getinge AB, LivaNova PLC, Medtronic, MicroPort Scientific Corporation, NIPRO, OriGen Biomedical, and Terumo Cardiovascular Systems Corporation.